Hydroxychloroquine, a potent anti-malarial and anti-inflammatory drug, holds immense potential for various therapeutic applications. Despite ongoing clinical debates regarding its efficacy for COVID-19 treatment, the global hydroxychloroquine market remains vibrant and promises significant growth opportunities for manufacturers and exporters. Navigating this complex landscape, however, requires careful planning and strategic execution. This guide equips you with the knowledge and tools to identify key global buyers, capitalize on market trends, and implement winning strategies to dominate the hydroxychloroquine trade. Top Hydroxychloroquine Buyers by Region: North America: Abbott Laboratories, Pfizer, Teva Pharmaceuticals, Mallinckrodt Pharmaceuticals Europe: Sanofi, Novartis, Bayer, GSK Asia Pacific: Cipla, Sun Pharmaceutical Industries, Zydus Cadila, Torrent Pharmaceuticals Latin America: Grupo Farmacéutico…